A possible conclusion of the data discussed in the paper was that breast cancer patients with hormone receptor positive breast cancer may be better protected against COVID-19 infections due to higher estrogen levels, which showed a negative correlation with severity of COVID-19 infection in a multi-center study performed in China in 2020 (34). Here, NR4A1 is linked to breast carcinoma.